367 related articles for article (PubMed ID: 19426677)
1. Electrophysiologic characterization of a novel hERG channel activator.
Su Z; Limberis J; Souers A; Kym P; Mikhail A; Houseman K; Diaz G; Liu X; Martin RL; Cox BF; Gintant GA
Biochem Pharmacol; 2009 Apr; 77(8):1383-90. PubMed ID: 19426677
[TBL] [Abstract][Full Text] [Related]
2. 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels.
Gordon E; Lozinskaya IM; Lin Z; Semus SF; Blaney FE; Willette RN; Xu X
Mol Pharmacol; 2008 Mar; 73(3):639-51. PubMed ID: 18042732
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological removal of human ether-à-go-go-related gene potassium channel inactivation by 3-nitro-N-(4-phenoxyphenyl) benzamide (ICA-105574).
Gerlach AC; Stoehr SJ; Castle NA
Mol Pharmacol; 2010 Jan; 77(1):58-68. PubMed ID: 19805508
[TBL] [Abstract][Full Text] [Related]
4. The membrane permeable calcium chelator BAPTA-AM directly blocks human ether a-go-go-related gene potassium channels stably expressed in HEK 293 cells.
Tang Q; Jin MW; Xiang JZ; Dong MQ; Sun HY; Lau CP; Li GR
Biochem Pharmacol; 2007 Dec; 74(11):1596-607. PubMed ID: 17826747
[TBL] [Abstract][Full Text] [Related]
5. Cardiac glycosides as novel inhibitors of human ether-a-go-go-related gene channel trafficking.
Wang L; Wible BA; Wan X; Ficker E
J Pharmacol Exp Ther; 2007 Feb; 320(2):525-34. PubMed ID: 17095614
[TBL] [Abstract][Full Text] [Related]
6. The effects of propofol on macroscopic and single channel sodium currents in rat ventricular myocytes.
Saint DA
Br J Pharmacol; 1998 Jun; 124(4):655-62. PubMed ID: 9690856
[TBL] [Abstract][Full Text] [Related]
7. [Effect of sophocarpine on HERG K+ channels].
Qi ZP; Shi SS; Zhao XL; Zhao WX; Bai YL; Lü YJ; Li BX; Yang BF
Yao Xue Xue Bao; 2008 Jan; 43(1):44-9. PubMed ID: 18357730
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological effects of the anti-cancer drug lapatinib on cardiac repolarization.
Lee HA; Kim EJ; Hyun SA; Park SG; Kim KS
Basic Clin Pharmacol Toxicol; 2010 Jul; 107(1):614-8. PubMed ID: 20406211
[TBL] [Abstract][Full Text] [Related]
9. Time course and voltage dependence of expressed HERG current compared with native "rapid" delayed rectifier K current during the cardiac ventricular action potential.
Hancox JC; Levi AJ; Witchel HJ
Pflugers Arch; 1998 Nov; 436(6):843-53. PubMed ID: 9799397
[TBL] [Abstract][Full Text] [Related]
10. Block of hERG channel by ziprasidone: biophysical properties and molecular determinants.
Su Z; Chen J; Martin RL; McDermott JS; Cox BF; Gopalakrishnan M; Gintant GA
Biochem Pharmacol; 2006 Jan; 71(3):278-86. PubMed ID: 16325148
[TBL] [Abstract][Full Text] [Related]
11. The action of the novel gastrointestinal prokinetic prucalopride on the HERG K+ channel and the common T897 polymorph.
Chapman H; Pasternack M
Eur J Pharmacol; 2007 Jan; 554(2-3):98-105. PubMed ID: 17109852
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of coronary vasodilator papaverine on heterologously-expressed HERG currents in Xenopus oocytes.
Kim CS; Lee N; Son SJ; Lee KS; Kim HS; Kwak YG; Chae SW; Lee SD; Jeon BH; Park JB
Acta Pharmacol Sin; 2007 Apr; 28(4):503-10. PubMed ID: 17376289
[TBL] [Abstract][Full Text] [Related]
13. Na+ permeation and block of hERG potassium channels.
Gang H; Zhang S
J Gen Physiol; 2006 Jul; 128(1):55-71. PubMed ID: 16769794
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen peroxide modifies the kinetics of HERG channel expressed in a mammalian cell line.
Bérubé J; Caouette D; Daleau P
J Pharmacol Exp Ther; 2001 Apr; 297(1):96-102. PubMed ID: 11259532
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of berberine on IK1, IK, and HERG channels of cardiac myocytes.
Li BX; Yang BF; Zhou J; Xu CQ; Li YR
Acta Pharmacol Sin; 2001 Feb; 22(2):125-31. PubMed ID: 11741516
[TBL] [Abstract][Full Text] [Related]
16. Effects of cyamemazine on hERG, INa, ICa, Ito, Isus and IK1 channel currents, and on the QTc interval in guinea pigs.
Crumb W; Llorca PM; Lancon C; Thomas GP; Garay RP; Hameg A
Eur J Pharmacol; 2006 Feb; 532(3):270-8. PubMed ID: 16494862
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological characterization of a small molecule activator on human ether-a-go-go-related gene (hERG) potassium channel.
Dong X; Liu Y; Niu H; Wang G; Dong L; Zou A; Wang K
J Pharmacol Sci; 2019 Jul; 140(3):284-290. PubMed ID: 31481348
[TBL] [Abstract][Full Text] [Related]
18. Biophysical characterization of the new human ether-a-go-go-related gene channel opener NS3623 [N-(4-bromo-2-(1H-tetrazol-5-yl)-phenyl)-N'-(3'-trifluoromethylphenyl)urea].
Hansen RS; Diness TG; Christ T; Wettwer E; Ravens U; Olesen SP; Grunnet M
Mol Pharmacol; 2006 Oct; 70(4):1319-29. PubMed ID: 16825484
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel.
Kang J; Chen XL; Wang H; Ji J; Cheng H; Incardona J; Reynolds W; Viviani F; Tabart M; Rampe D
Mol Pharmacol; 2005 Mar; 67(3):827-36. PubMed ID: 15548764
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the slowly inactivating sodium current INa2 in canine cardiac single Purkinje cells.
Bocchi L; Vassalle M
Exp Physiol; 2008 Mar; 93(3):347-61. PubMed ID: 17993508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]